Hypocomplementemic urticarial vasculitis syndrome (HUVS) is a rare small-vessel vasculitis of unknown etiology first described by McDuffie We hypothesize that omalizumab is safe and effective in milder forms of HUVS, but not in those involving the kidney and/or the lung, which usually require immunosuppressive drugs
Nucera, E., Basta, F., Buonomo, A., Mezzacappa, S., Margiotta, D., Antonelli Incalzi, R., Schiavino, D., A Case of Hypocomplementemic Urticarial Vasculitis Syndrome Successfully Treated With Omalizumab, <<JOURNAL OF INVESTIGATIONAL ALLERGOLOGY & CLINICAL IMMUNOLOGY>>, 2017; (27): 382-384 [http://hdl.handle.net/10807/120188]
Autori: | ||
Titolo: | A Case of Hypocomplementemic Urticarial Vasculitis Syndrome Successfully Treated With Omalizumab | |
Data di pubblicazione: | 2017 | |
Abstract: | Hypocomplementemic urticarial vasculitis syndrome (HUVS) is a rare small-vessel vasculitis of unknown etiology first described by McDuffie We hypothesize that omalizumab is safe and effective in milder forms of HUVS, but not in those involving the kidney and/or the lung, which usually require immunosuppressive drugs | |
Lingua: | Inglese | |
Rivista: | ||
Citazione: | Nucera, E., Basta, F., Buonomo, A., Mezzacappa, S., Margiotta, D., Antonelli Incalzi, R., Schiavino, D., A Case of Hypocomplementemic Urticarial Vasculitis Syndrome Successfully Treated With Omalizumab, <<JOURNAL OF INVESTIGATIONAL ALLERGOLOGY & CLINICAL IMMUNOLOGY>>, 2017; (27): 382-384 [http://hdl.handle.net/10807/120188] | |
Appare nelle tipologie: | Articolo in rivista, Nota a sentenza |